Contracts › 75F40122F19002
75F40122F19002: Understanding the Prevalence, Experiences, Knowledge, and Perceptions of Falsified and Unapproved Pharmaceuticals in an Enriched Population Being Assessed for or Entering Substance Use Disorder Treatment
Awarded to Integrated Behavioral Health, Inc. by Food and Drug Administration (FDA).
$1.0Mobligated
$1.0Mpotential value
28 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40122F19002 |
|---|---|
| Vehicle | 75F40121D00032 |
| Awardee | Integrated Behavioral Health, Inc. |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | B529 Special Studies/Analysis- Scientific Data |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 16 September 2022 to 28 September 2027 |
| Potential end | 28 September 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record